1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Allergy and Infectious Diseases Research is a grant program from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, that funds scientific research to advance understanding, diagnosis, treatment, and prevention of infectious, immunologic, and allergic diseases.
NIAID supports research across more than 60 disease areas including HIV, antimicrobial resistance, tuberculosis, influenza, food allergies, autoimmune diseases, neglected tropical diseases, and emerging infectious threats. The Institute operates with a . 6 billion annual budget.
Eligible applicants include universities, colleges, hospitals, laboratories, and other public or private nonprofit domestic institutions, as well as state and local units of government. Federal grant obligations for this program reached over . 17 billion in 2026.
Get alerted about grants like this
Get emailed when new opportunities from “Department of Health And Human Services” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
National Institute of Allergy and Infectious Diseases (NIAID) Resources for Researchers Division of Intramural Research Labs Research at Vaccine Research Center Intramural Scientist & Clinician Directory Research Rules & Policies Allergy, Immunology & Transplantation Resources for Researchers Antimicrobial (Drug) Resistance Antimicrobial Resistance Threats Information for Researchers Risk Factors & Prevention Research Immune Tolerance Processes Disease-Specific Research Information for Researchers Autoimmune Lymphoproliferative Syndrome (ALPS) Basic & Preclinical Research Information for Researchers Information for Researchers Shiga Toxin-Producing E.
coli (STEC) Researching Ebola in Africa Information for Researchers Information for Researchers Why Food Allergy is a Priority for NIAID Characterizing Food Allergy & Addressing Related Disorders Information for Researchers Diagnosis & Management Guidelines Disease-Specific Research Information for Researchers Genomics & Advanced Technologies Pathogen-Based Initiatives Information for Researchers Information for Researchers Group A Streptococcal Infections Disease-Specific Research Information for Researchers Overview of the Immune System Features of an Immune Response Information for Researchers Information for Researchers Leprosy (Hansen's Disease) How NIAID is Addressing Lyme Disease Information for Researchers Parasite, Mosquito & Human Host Prevention, Treatment & Control Strategies Strategic Partnerships & Research Capacity Information for Researchers Information for Researchers Neglected Tropical Diseases Information for Researchers Translational & Clinical Research Cross-cutting Preparedness Molecular & Genetic Research Primary Immune Deficiency Diseases (PIDDs) Information for Researchers Animal Prion Diseases and Humans Information for Researchers Respiratory Syncytial Virus (RSV) Schistosomiasis (Bilharzia) Research in Endemic Regions Sexually Transmitted Infections (STIs) NIAID's Research Approach Information for Researchers Disease-Specific Research Information for Researchers Information for Researchers Disease-Specific Vaccines Information for Researchers Translational & Clinical Research Information for Researchers Biology, Genetics & Clinical Research NIAID's Approach to Women's Health Research Sex-Specific Health Challenges Facing Women Biennial Report (FY 2019-2020) Information for Researchers Why NIAID Is Researching Zika Virus Information for Researchers Find a Funding Opportunity NIAID Research Priorities Plan Your Budget & Personnel Additional Application Elements Research with Special Considerations After You Submit an Application Understand the Review Process Respond to Pre-Award Requests Negotiation & Initial Award Become a Healthy Volunteer Participant's Guide to Clinical Trials HIV and Emerging Infectious Diseases Laboratory of Infectious Diseases Primary Immune Deficiency Clinic Vaccine Research Center Clinical Studies Fill Out the Volunteer Form Q&A: Vaccine Clinical Studies Vaccine Clinical Studies Safeguards Clinical Trial Publications NIAID-Funded Research News Division of Allergy, Immunology, and Transplantation Division of Microbiology and Infectious Diseases Division of Extramural Activities Division of Clinical Research Division of Intramural Research Dr. Joseph J.
Kinyoun: Father of the NIH Dr. Joseph Kinyoun The Indispensable Forgotten Man Dr. Joseph Kinyoun: Selected Bibliography NIAID 60th Anniversary Timeline Research Training at NIAID Campuses Grant Programs that NIAID Funds AIDS Research Advisory Committee AIDS Vaccine Research Subcommittee Board of Scientific Counselors Members Advisory and Peer Review Committees Autoimmune Diseases Committee Website Policies and Notices External Link Icon and Disclaimers Freedom of Information Act (FOIA) Voluntarily Submitted Information Volunteer for Clinical Studies Healthy volunteers help NIAID to evaluate treatment and prevention options for a wide range of diseases and conditions in our mission areas.
Help us to improve human health. The New Strategic Vision for NIAID NIAID’s strategic aims are to address the most impactful infectious diseases that Americans currently face with evidence from gold standard science; and to support innovative research to address fundamental studies in immunology and allergic and autoimmune diseases to improve patient outcomes.
NIAID Approach to the NIH Unified Funding Strategy NIAID has a new, standardized process for assessing grant applications. The process considers scientific merit, public health impact, investigator-specific factors, research gaps, and alignment with HHS, NIH, and NIAID priorities. This approach complements NIH peer review to guide funding selections.
NIAID Discovery Leads to Novel Probiotic for Eczema NIAID researchers discovered that the bacteria, Roseomonas mucosa which occurs naturally as part of the typical microbiome present on healthy skin, can safely relieve eczema symptoms in adults and children. This discovery led to the availability of a topical eczema probiotic. Acting Director Jeffery Taubenberger, M.
D. , Ph. D.
Jeffery K. Taubenberger, M. D.
, Ph. D. Dr. Taubenberger was named the Acting Director of NIAID in April 2025.
He oversees a $6. 6 billion budget that supports research to advance the understanding, diagnosis, treatment and prevention of infectious, immunologic, and allergic diseases. He is known for sequencing, reconstruction, and characterization of the virus responsible for the 1918 influenza pandemic.
Learn more about Dr. Taubenberger Read NIAID's Latest News Releases Featured Areas of Research Refining the HIV Research Enterprise Information for Researchers All Diseases & Conditions Get the latest information on...
Opportunities & Announcements Sample Grant Applications NIAID Offices, Divisions & Centers Division of Intramural Research Research Conducted at NIAID Research Conducted at NIAID Division of Allergy, Immunology, and Transplantation Division of Microbiology and Infectious Diseases Division of Extramural Activities
According to the current listing, eligibility includes: Universities, colleges, hospitals, laboratories, and other public or private nonprofit domestic institutions, including State and local units of government, and individuals are eligible to make application for grant sup…. Confirm the full requirements in the official notice before applying.
The current listing shows recent federal obligations suggest $1,171,932,322 (2026). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Yes — Allergy and Infectious Diseases Research is offered by Department of Health And Human Services and this listing comes from SAM.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
This initiative will stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality of the disease and high costs to the health care system. Funding Opportunity Number: PA-14-058. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL.
The STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Elevance Health Foundation's FY2026 Maternal/Infant Health cycle offers grants around $1 million (1–3 years, 15% indirects) to reduce pre-term birth and severe maternal morbidity. But eligibility hinges on a specific 501(c)(3) subsection test, funding concentrates in 10 states plus national scalable programs, and a corporate payer-funder judges you on measurable outcomes, not need. Here is how to read this RFP and compete before the July 31 deadline.
Read articleElevance Health Foundation's maternal/infant health RFP closes July 31, 2026, part of a five-year, $150 million commitment. Last cycle it awarded 29 grants totaling $6.5M across the pregnancy continuum. Here is what the funder actually rewards — measurable disparity reduction, a 15% indirect-cost cap, and scalable models — plus how nonprofits in the 10 priority states should frame a competitive proposal.
Read article